Gossamer Bio(DE:4GB0)
€8.840.00 (0.00%)
DE:4GB0
Gossamer Bio financials statements
€8.84
At close:0.00 (0.00%)
Gossamer Bio (4GB0) Financial Statements
10 Followers
Gossamer Bio Financial Overview
Gossamer Bio's market cap is currently $62.12M. The company's EPS TTM is $-35.76; its P/E ratio is -0.33; Gossamer Bio is estimated to report earnings on March 12, 2027, and the estimated EPS forecast is $-2.26. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 48.47M | $ 114.70M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 47.47M | $ 114.70M | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -163.25M | $ -59.92M | $ -183.76M | $ -218.59M | $ -216.12M |
| EBITDA | $ -158.47M | $ -39.97M | $ -161.92M | $ -211.07M | $ -209.40M |
| Net Income | $ -170.37M | $ -56.53M | $ -179.82M | $ -229.38M | $ -234.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 136.93M | $ 294.52M | $ 296.43M | $ 255.68M | $ 325.22M |
| Total Assets | $ 172.25M | $ 315.29M | $ 311.92M | $ 272.45M | $ 343.66M |
| Total Debt | $ 202.91M | $ 202.88M | $ 212.46M | $ 225.74M | $ 185.24M |
| Net Debt | $ 165.17M | $ 156.81M | $ 180.35M | $ 113.77M | $ 1.83M |
| Total Liabilities | $ 295.01M | $ 285.80M | $ 249.15M | $ 260.37M | $ 222.19M |
| Stockholders' Equity | $ -122.76M | $ 29.49M | $ 62.77M | $ 12.08M | $ 121.46M |
| Cash Flow | |||||
| Free Cash Flow | $ -171.34M | $ -3.47M | $ -159.16M | $ -187.51M | $ -190.51M |
| Operating Cash Flow | $ -171.27M | $ -3.47M | $ -159.16M | $ -187.03M | $ -188.89M |
| Investing Cash Flow | $ 156.36M | $ 29.02M | $ -110.97M | $ -1.03M | $ -117.43M |
| Financing Cash Flow | $ 6.42M | $ -11.49M | $ 190.15M | $ 117.09M | $ 3.33M |
Currency in USD
